SAGE-547: Additional Phase I/II data

Data from 17 evaluable adults with SRSE in an open-label, U.S. Phase I/II trial showed that 12 (71%) patients were successfully weaned off their anesthetic agents while receiving IV SAGE-547 for 5 day...